Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0035412 (
rhabdomyosarcoma
)
6,156
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The E1A-targeted transcription factor
E4F1
is a key player in the control of mammalian embryonic and somatic cell proliferation and survival. Mouse embryos lacking E4F die at an early developmental stage, whereas enforced expression of
E4F1
in various cell lines inhibits cell cycle progression.
E4F1
-antiproliferative effects have been shown to depend on its capacity to repress transcription and to interact with pRb and p53. Here we show that full-length E4F1 protein (p120(
E4F1
)) but not its E1A-activated and truncated form (p50(
E4F1
)), interacts directly in vitro and in vivo with the LIM-only protein FHL2, the product of the p53-responsive gene FHL2/DRAL (downregulated in
rhabdomyosarcoma
Lim protein). This
E4F1
-FHL2 association occurs in the nuclear compartment and inhibits the capacity of
E4F1
to block cell proliferation. Consistent with this effect, ectopic expression of FHL2 inhibits
E4F1
repressive effects on transcription and correlates with a reduction of nuclear
E4F1
-p53 complexes. Overall, these results suggest that FHL2/DRAL is an inhibitor of
E4F1
activity. Finally, we show that endogenous
E4F1
-FHL2 complexes form in U2OS cells upon UV-light-induced nuclear accumulation of FHL2.
...
PMID:The LIM-only protein FHL2 is a negative regulator of E4F1. 1665 57